Matched on what MANÜ Telehealth offers: medications, brand-name access, the video visit, an oral option, price and where it serves. Each one links to our full review.
No recurring price we could quote
Actin’s current public product page did not expose a readable price or plan menu. Its previously listed medication rates remain unconfirmed.
Why it's here: the same medications, compounded medication and no video visit.
- Neither Actin nor MANÜ Telehealth requires a live video visit to get started.
No recurring price we could quote
Citizen Meds previously displayed discounted semaglutide and tirzepatide prices without resolving whether the markdowns were introductory or ongoing.
Why it's here: the same medications, compounded medication and no video visit.
- Neither Citizen Meds nor MANÜ Telehealth requires a live video visit to get started.
No recurring price we could quote
Lumen’s public price components currently show zero placeholders and incomplete figures. A reliable medication charge or renewal total is not confirmed.
Why it's here: the same medications, compounded medication and no video visit.
- Neither Lumen Meds nor MANÜ Telehealth requires a live video visit to get started.
No recurring price we could quote
Earlier Neo Soma pages described a six-week semaglutide introductory offer followed by four-week billing, and a separate six-week tirzepatide purchase.
Why it's here: the same medications, compounded medication and no video visit.
- Neither Neo Soma Healthcare nor MANÜ Telehealth requires a live video visit to get started.
No recurring price we could quote
HumeCare combines physician-guided GLP-1 care with body-composition tracking and a free app. Current medication prices are not published on the homepage.
Why it's here: the same medications, compounded medication and no video visit.
- Neither HumeCare+ nor MANÜ Telehealth requires a live video visit to get started.
- HumeCare+ lists an oral option (a pill or under-the-tongue form); MANÜ Telehealth doesn't.
- HumeCare+ lists a narrower service area; MANÜ Telehealth doesn't publish a full state list.
No recurring price we could quote
Peter MD advertises tirzepatide at $149 to start, then $249 per month billed quarterly for a 60 mg option.
Why it's here: compounded medication and no video visit.
- Peter MD also offers tirzepatide, which we didn't find at MANÜ Telehealth.
- Neither Peter MD nor MANÜ Telehealth requires a live video visit to get started.
- Peter MD lists a narrower service area; MANÜ Telehealth doesn't publish a full state list.